Cargando…
Refractory flare-up of severe bronchial asthma controlled with mepolizumab due to Pneumocystis pneumonia: a case report
BACKGROUND: Biologics dramatically improve symptoms of severe asthma; however, various exacerbating factors may induce flare-up. Pneumocystis spp. have not been reported as a cause of asthma exacerbation during biologic use, although patients with severe asthma have high levels of antibodies against...
Autores principales: | Takeda, Kazuya, Sumi, Toshiyuki, Nagahisa, Yuta, Matsuura, Keigo, Sekikawa, Motoki, Watanabe, Hiroki, Yamada, Yuichi, Chiba, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035245/ https://www.ncbi.nlm.nih.gov/pubmed/35461263 http://dx.doi.org/10.1186/s13223-022-00678-y |
Ejemplares similares
-
Successful management of severe bronchial asthma exacerbated by anti‐PD‐L1 treatment: A report of two cases
por: Sumi, Toshiyuki, et al.
Publicado: (2021) -
Delayed local reaction at a previous injection site reaction with dupilumab
por: Sumi, Toshiyuki, et al.
Publicado: (2021) -
Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech)
por: Sumi, Toshiyuki, et al.
Publicado: (2021) -
Pseudocirrhosis due to liver metastasis from lung adenocarcinoma
por: Shijubou, Naoki, et al.
Publicado: (2021) -
Coronavirus Disease 2019 Vaccine-Induced Flare-Up of Severe Bronchial Asthma Previously Controlled With Dupilumab: A Case Report
por: Sumi, Toshiyuki, et al.
Publicado: (2023)